ARCHIVES

Who Will Determine Pay Lines For Each Program at NCI? Upton Suggests A Collective Approach

This article is from The Cancer Letter archive.

Vol. 04 No. 07 | February 17, 1978

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Also in This 8-page Issue: NCI Seeks $6.17 Billion in “Bypass” Budget Request, But Faces Shortfall In Its Actual Budget.

January 14, 2005

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

SWOG Launching New Study Based on Recurrence Test Scores

April 29, 2011

In Brief: King Faisal Prize Next Year Will Be Awarded For Leukemia Research; Yarbro Wins Fulbirght

March 20, 1987

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010